The association between depressive symptoms and executive function in type 1 diabetes population: A scoping review

Chawisa Dandamrongrak,Kaitlyn Rechenberg,Jumpee Granger,Ayesha Johnson,Kailei Yan,Jennifer Kue
DOI: https://doi.org/10.1016/j.pcd.2024.04.001
IF: 2.567
2024-04-25
Primary Care Diabetes
Abstract:Purpose The purpose of this study was to explore the existing literature on the relationship between depressive symptoms and executive function in patients with type 1 diabetes (T1DM) across the lifespan. Methods The scoping review followed the PRISMA protocol by using three databases: PubMed, CINAHL, and PsycINFO on May 14, 2023. Primary research that included reported executive function and the association with depressive symptoms was included in the review. Results Of 1470 de-duplicated publications identified, nine articles were included in the review. Five studies evaluated the T1DM population, while four studies evaluated T1DM and type 2 diabetes (T2DM) as an aggregate result. Three studies indicated an association between depressive symptoms and executive function in adults with T1DM, and four studies indicated an association between depressive symptoms and executive function in adults with either T1DM or T2DM. In general, participants who reported depressive symptoms also exhibited poor executive function. However, two studies did not find an association between depressive symptoms and executive function. Conclusion In summary, the seven studies in this review suggest that individuals with T1DM who report depressive symptoms are at a higher risk of poor executive function; a clear association between depressive symptoms and executive function in individuals with T1DM remains inconclusive. There is a need to explore this relationship in the future.
endocrinology & metabolism,primary health care
What problem does this paper attempt to address?